References
- HirschhornJGenomewide association studies–illuminating biologic pathwaysN Engl J Med20093601699170119369661
- FeldmannMTranslating molecular insights in autoimmunity into effective therapyAnnu Rev Immunol20092712719007330
- TaylorCFPatonNWLilleyKSThe minimum information about a proteomics experiment (MIAPE)Nat Biotechnol200725888789317687369
- PanSAebersoldRChenRMass spectrometry based targeted protein quantification: methods and applicationsJ Proteome Res2009878779719105742
- KimSMisraASNP genotyping: technologies and biomedical applicationsAnnu Rev Biomed Engin20079289320
- FathmanCGLuis SoaresLChanSMUtzPJAn array of possibilities for the study of autoimmunityNature200543560561115931213
- CallesenAMadsenJVachWKruseTMogensenOJensenOSerum protein profiling by solid phase extraction and mass spectrometry: A future diagnostics tool?Proteomics200991428144119235169
- BalboniIChanSMKattahMTenenbaumJDButteAJUtzPJMultiplexed protein array platforms for analysis of autoimmune diseasesAnnu Rev Immunol20062439141816551254
- LettreGRiouxJDAutoimmune diseases: insights from genome-wide association studiesHum Mol Genet200817R2R116R12118852199
- GregersenPKOlssonLMRecent advances in the genetics of autoimmune diseaseAnnu Rev Immunol20092736339119302045
- SchenaMShalonDDavisRWBrownPOQuantitative monitoring of gene expression patterns with a complementary DNA microarrayScience199527052354674707569999
- MarcotteEMPellegriniMThompsonMJYeatesTOEisenbergDA combined algorithm for genome-wide prediction of protein functionNature19994026757838610573421
- MacBeathGSchreiberSPrinting proteins as microarrays for high-throughput function determinationScience20002891760176310976071
- ArnottDShabanowitzJHuntDFMass spectrometry of proteins and peptides: sensitive and accurate mass measurement and sequence analysisClin Chem199339200520108375091
- van BaarsenLVosslamberSTijssenMPharmacogenomics of interferon-beta therapy in multiple sclerosis: baseline IFN signature determines pharmacological differences between patientsPLoS One200834e192718382694
- BosCvan BaarsenLTimmerTMolecular subtypes of systemic sclerosis in association with anti-centromere antibodies and digital ulcersGenes Immun200910321021819129850
- ChabasDBaranziniSEMitchellDThe influence of the pro-inflammatory cytokine, osteopontin, on autoimmune demyelinating diseaseScience20012941731173511721059
- OusmanSTomookaBvan NoortJProtective and therapeutic role for alphaB-crystallin in autoimmune demyelinationNature2007448715247447917568699
- HurEYoussefSHawsMZhangSSobelRSteinmanLOsteopontin-induced relapse and progression of autoimmune brain disease through enhanced survival of activated T cellsNat Immunol200781748317143274
- HanMHwangSRoyDProteomic analysis of active multiple sclerosis lesions reveals therapeutic targetsNature200845171821076108118278032
- O’ConnorKCMcLaughlinKADe JagerPLSelf-antigen tetramers discriminate between myelin autoantibodies to native or denatured proteinNat Med200713221121717237795
- ObermeierBMenteleRMalotkaJMatching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosisNat Med200814668869318488038
- van MühlenCATanEMAutoantibodies in the diagnosis of systemic rheumatic diseasesArthritis Rheum199524323358
- ScofieldRHAutoantibodies as predictors of diseaseLancet200436394201544154615135604
- LaGasseJMBrantleyMSLeechNJSuccessful prospective prediction of type 1 diabetes in schoolchildren through multiple defined autoantibodies: an 8-year follow-up of the Washington State Diabetes Prediction StudyDiabetes Care200225350551111874938
- SmolenJAletahaDGrisarJRedlichKSteinerGWagnerOThe need for prognosticators in rheumatoid arthritis. Biological and clinical markers: where are we now?Arthritis Res Ther200810320818557991
- FurlanRDefinition of non-responders: biological markersNeurol Sci200829S214S21518690495
- ZetheliusBBerglundLSundstromJUse of multiple biomarkers to improve the prediction of death from cardiovascular causesN Engl J Med2008358202107211618480203
- SchellekensGAde JongBAvan den HoogenFHvan de PutteLBvan VenrooijWJCitrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodiesJ Clin Invest19981012732819421490
- KlareskogLRonnelidJLundbergKPadyukovLAlfredssonLImmunity to citrullinated proteins in rheumatoid arthritisAnnu Rev Immunol20082665167518173373
- NishimuraKSugiyamaDKogataYMeta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for theumatoid arthritisAnn Intern Med20071461179780817548411
- FritzlerMWiikATanEA critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. III. Comparative performance characteristics of academic and manufacturers’ laboratoriesJ Rheumatol200330112374238114677180
- RobinsonWDiGennaroCHueberWAutoantigen microarrays for multiplex characterization of autoantibody responsesNat Med20028329530111875502
- HueberWTomookaBHZhaoXProteomic analysis of secreted proteins in early rheumatoid arthritis: anti-citrulline autoreactivity is associated with up regulation of proinflammatory cytokinesAnn Rheum Dis200766671271916901957
- RobinsonWFontouraPLeeBProtein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitisNat Biotechnol2003211033103912910246
- KiddBHoPSharpeOEpitope spreading to citrullinated antigens in mouse models of autoimmune arthritis and demyelinationArthritis Res Ther200810R11918826638
- HillJBellDBrintnellWArthritis induced by posttranslationally modified (citrullinated) fibrinogen in DR4-IE transgenic miceJ Exp Med2008205496797918391064
- HueberWKiddBATomookaBHAntigen microarray profiling of autoantibodies in rheumatoid arthritisArthritis Rheum20055292645265516142722
- KanterJNarayanaSHoPLipid microarrays identify key mediators of autoimmune brain inflammationNat Med20061213814216341241
- HueberWTomookaBBatliwallaFBlood autoantibody and cytokine profiles predict response to anti-tumor necrosis factor therapy in rheumatoid arthritisArthritis Res Ther2009113R7919476613
- SilvermanGSrikrishnanRGermarKGenetic imprinting of autoantibody repertoires in systemic lupus erythematosus patientsClin Exp Immunol200815310211618510544
- ZhenQLXieCWuTIdentification of autoantibody clusters that best predict lupus disease activity using glomerular proteome arraysJ Clin Invest2005115123428343916322790
- CambridgeGIsenbergDEdwardsJB cell depletion therapy in systemic lupus erythematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical responseAnn Rheum Dis2008671011101617962238
- ArbuckleMMcClainMRubertoneMDevelopment of autoantibodies before the clinical onset of systemic lupus erythematosusN Engl J Med2003349161526153314561795
- FeserMDerberLDeaneKPlasma 25,OH vitamin D concentrations are not associated with rheumatoid arthritis (RA)-related autoantibodies in individuals at elevated risk for RAJ Rheumatol200936594394619286844
- NielenMvan SchaardenburgDReesinkHSpecific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donorsArthritis Rheum200450238038614872479
- Rantapää-DahlqvistSde JongBBerglinEAntibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritisArthritis Rheum200348102701270514558071
- DwivediRDhindsaNKrokhinOCortensJWilkinsJEl-GabalawyHThe effects of infliximab therapy on the serum proteome of rheumatoid arthritis patientsArthritis Res Ther2009112R3219265537
- AndersonNLAndersonNGThe human plasma proteome: history, character, and diagnostic prospectsMol Cell Proteomics2002184586712488461
- JacksonDHerathASwintonJConsiderations for powering a clinical proteomics study: Normal variability in the human plasma proteomeProteomics Clin Appl20093394407
- AndersonNEsquer-BlascoRHofmannJAndersonNA two-dimensional gel database of rat liver proteins useful in gene regulation and drug effects studiesElectrophoresis1991129079301724422
- RaiAStemmerPZhangZAnalysis of Human Proteome Organization Plasma Proteome Project (HUPO PPP) reference specimens using surface enhanced laser desorption/ionization-time of flight (SELDI-TOF) mass spectrometry: multi-institution correlation of spectra and identification of biomarkersProteomics200553467347416052624
- TabushiYNakanishiTTakeuchiTDetection of citrullinated proteins in synovial fluids derived from patients with rheumatoid arthritis by proteomics-based analysisAnn Clin Biochem200845441341718583628
- KinlochALundbergKWaitRSynovial fluid is a site of citrullination of autoantigens in inflammatory arthritisArthritis Rheum20085882287229518668562
- RodriguezAEspinaBEspinaVLiottaLAutomated laser capture micro-dissection for tissue proteomicsMethods Mol Biol2008441719018370312
- ChaussabelDQuinnCShenJA modular analysis framework for blood genomics studies: application to systemic lupus erythematosusImmunity20082991118631452
- DoyleHMamulaMPosttranslational modifications of self-antigensAnn N Y Acad Sci200510501916014515
- DoyleHMamulaMA failure to repair self-proteins leads to T cell hyperproliferation and autoantibody productionJ Immunol200317162840284712960305
- KattahMAlemiGThibaultDBalboniIUtzPA new two-color Fab labeling method for autoantigen protein microarraysNat Methods20063974575116929321
- ThalerMBuhlAWelterHBiosensor analyses of serum autoantibodies: application to antiphospholipid syndrome and systemic lupus erythematosusAnal Bioanal Chem200939351417142918759105
- AllantazFChaussabelDStichwehDBlood leukocyte microarrays to diagnose systemic onset juvenile idiopathic arthritis and follow the response to IL-1 blockadeJ Exp Med200720492131214417724127
- PascualVAllantazFPatelPPaluckaAChaussabelDBanchereauJHow the study of children with rheumatic diseases identified interferon-alpha and interleukin-1 as novel therapeutic targetsImmunol Rev2008223395918613829
- NakouMKnowltonNFrankMGene expression in systemic lupus erythematosus: bone marrow analysis differentiates active from inactive disease and reveals apoptosis and granulopoiesis signaturesArthritis Rheum200858113541354918975309
- ChaussabelDAllmanWMejiasAAnalysis of significance patterns identifies ubiquitous and disease-specific gene-expression signatures in patient peripheral blood leukocytesAnn NY Acad Sci2005106214615416461797
- AdenNShiwenXAdenDProteomic analysis of scleroderma lesional skin reveals activated wound healing phenotype of epidermal cell layerRheumatology200847121754176018829709
- BaechlerEBauerJSlatteryCAn interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activityMol Med2007131–2596817515957
- HinksABartonAShephardNIdentification of a novel susceptibility locus for juvenile idiopathic arthritis by genome-wide association analysisArthritis Rheum200960125826319116933
- MaoLDongHYangPMALDI-TOF/TOF-MS reveals elevated serum haptoglobin and amyloid A in Behçet’s diseaseJ Proteome Res20087104500450718754684
- RottoliPMagiBPerariMCytokine profile and proteome analysis in bronchoalveolar lavage of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosisProteomics2005551423143015761959
- AndreasKHauplTLubkeCAntirheumatic drug response signatures in human chondrocytes: potential molecular targets to stimulate cartilage regenerationArthritis Res Ther2009111R1519192274
- HaiderASLowesMASuarez-FarinasMIdentification of cellular pathways of “Type 1,” Th17 T Cells, and TNF- and inducible nitric oxide synthase-producing dendritic cells in autoimmune inflammation through pharmacogenomic study of cyclosporine A in psoriasisJ Immunol200818031913192018209089
- QuintanaFFarezMWeinerHSystems biology approaches for the study of multiple sclerosisJ Cell Mol Med20081241087109318505469
- AltshulerDDalyMLanderEGenetic mapping in human diseaseScience200832288188818988837
- RischNMerikangasKThe future of genetic studies of complex human diseasesScience1996273151615178801636
- JakobsdottirJGorinMConleyYFerrellRWeeksDInterpretation of genetic association studies: markers with replicated highly significant odds ratios may be poor classifiersPLoS Genet200952e100033719197355
- Wellcome Trust Case Control ConsortiumGenome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controlsNature2007447714566167817554300
- DuerrRHTaylorKDBrantSRRiouxJDSilverbergMSA genome-wide association study identifies IL23R as an inflammatory bowel disease geneScience2006314146117068223
- WangKZhangHKugathasanSDiverse genome-wide association studies associate the IL12/IL23 pathway with Crohn diseaseAm J Human Genet200984339940519249008
- WeersmaRKStokkersPCFCleynenIConfirmation of multiple Crohn’s disease susceptibility Loci in a large Dutch-Belgian cohortAm J Gastroenterol2009104363063819174780
- BarrettJCHansoulSNicolaeDLChoJHDuerrRHGenome-wide association defines more than 30 distinct susceptibility loci for Crohn’s diseaseNat Genet20084095596218587394
- OguraYBonenDKInoharaNNicolaeDLChenFFA frameshift mutation in NOD2 associated with susceptibility to Crohn’s diseaseNature200141160360611385577
- HugotJPLaurent-PuigPGower-RousseauCOlsonJMLeeJCMapping of a susceptibility locus for Crohn’s disease on chromosome 16Nature19963798218238587604
- RiouxJDXavierRJTaylorKDSilverbergMSGoyettePGenome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesisNat Genet20073959660417435756
- ParkesMBarrettJCPrescottNJTremellingMAndersonCASequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn’s disease susceptibilityNat Genet20073983083217554261
- CurtinKIlesMCampNIdentifying rarer genetic variants for common complex diseases: Diseased versus neutral discovery panelsAnn Hum Genet2009731546019132978
- AlexPGucekMLiXApplications of proteomics in the study of inflammatory bowel diseases: Current status and future directions with available technologiesInflamm Bowel Dis200915461662918844215
- MeuwisMAFilletMGeurtsPBiomarker discovery for inflammatory bowel disease, using proteomic serum profilingBiochem Pharmacol20077391422143317258689
- MeuwisMAFilletMLutteriLProteomics for prediction and characterization of response to infliximab in Crohn‘s disease: A pilot studyClin Biochem2008411296096718489908
- ShkodaAWernerTDanielHGunckelMRoglerGHallerDDifferential protein expression profile in the intestinal epithelium from patients with inflammatory bowel diseaseJ Proteome Res2007631114112517330946
- BowcockAMGenomics: Guilt by associationNature2007447714564564617554292
- RifaiNGilletteMCarrSProtein biomarker discovery and validation: the long and uncertain path to clinical utilityNature Biotechnol20062497198316900146
- MaurerMProteomics of brain extracellular fluid (ECF) and cerebrospinal fluid (CSF)Mass Spectrom Rev200810.1002/mas.20213
- AvasaralaJCerebrospinal fluid proteomics - Work in progressEurop J Neurol2008159891892
- CayrolRWosikKBerardJLActivated leukocyte cell adhesion molecule promotes leukocyte trafficking into the central nervous systemNat Immunol20089213714518157132